Thanks to the introduction of new monoclonal antibodies and vaccines. The respiratory syncytial virus (RSV) prophylaxis ...

In a new study, the RSV drug nirsevimab was 93% effective at preventing young children from being hospitalized for the ...

Pharmac has announced that, from January 1 2025, it will fund palivizumab - a medicine that prevents serious illness from ...

Meanwhile, Pharmac's decision to fund the budesonide, glycopyrronium and formoterol aerosol inhaler is expected to help 5000 ...

Pharmac will also fund osimertinib for people with a type of advanced non-small cell lung cancer. About 20 percent of people with non-small cell lung cancer have a mutation in their cancer that can be ...

Pharmac has announced that, from January 1 2025, it will fund palivizumab - a medicine that prevents serious illness from respiratory syncytial virus (RSV) in high-risk babies and young children - as ...

For young children, antibody products such as Nirsevimab and Palivizumab offer protection. Nirsevimab is recommended for all infants younger than 8 months during their first RSV season.

The Global News Morning team: Jason Pires, Sonia Sunger, Mark Madryga and Katelin Owsianski and Rock 101 Willy in the Morning will be LIVE on location. Taylor Swift told the crowd that the ...

The suspected madman behind a deadly stabbing spree in Manhattan Monday has a long criminal history — and had just walked free from Rikers Island a month before the terrifying attacks, The Post ...

The IAEA agency says Tehran’s nuclear programme has "spawned in every direction" over the last decade. Women's rights campaigner Narges Mohammadi recently underwent surgery to remove a tumour ...

Background: Since its introduction, palivizumab has been used to prevent respiratory syncytial virus (RSV) infection in high-risk populations. Recommendations for palivizumab administration ...